Globalworld globe
United Kingdom
North America
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

ASX Announcement: Green Whistle receives regulatory and marketing approval in the United Kingdom

Oct 28, 2015Cathy WilsonNews

28 October 2015

ASX ANNOUNCEMENT

Green Whistle receives regulatory and marketing approval in the United Kingdom

Medical Developments International Limited (ASX:MVP) is delighted to announce that it has received final approval from the Medicines and Healthcare Products Regulatory Agency (MHRA)? to market and sell its inhaled analgesic product, ?Penthrox? indicated for trauma and associated pain, in the United Kingdom.

To read the full announcement click on the following link: ?Penthrox receives regulatory and marketing approval in the UK?

 

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Appointment of Non-Executive Director – Mary Sontrop

    5 March 2021 ASX ANNOUNCE...

  • FY21 Half Year Report and Accounts

    26 February 2021 ASX ANNO...

  • MVP Completes $25m Placement

    14 December 2020 ASX ANNO...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me


Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: mdi@medicaldev.com
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: medinf@medicaldev.com

Email Newsletter

Sign up to our newsletter to receive MDI corporate, investor  & media news.